Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Gains from Sales and Divestitures (2023 - 2025)

Dna X's Gains from Sales and Divestitures history spans 3 years, with the latest figure at $42956.0 for Q4 2025.

  • Quarterly results put Gains from Sales and Divestitures at $42956.0 for Q4 2025, down 25.45% from a year ago — trailing twelve months through Dec 2025 was $42956.0 (down 25.45% YoY), and the annual figure for FY2025 was $42956.0, down 25.45%.
  • Gains from Sales and Divestitures for Q4 2025 was $42956.0 at Dna X, roughly flat from $42956.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $773960.0 in Q2 2025 to a low of $2149.0 in Q1 2025.
  • The 3-year median for Gains from Sales and Divestitures is $45442.5 (2024), against an average of $225039.9.
  • The sharpest move saw Gains from Sales and Divestitures plummeted 92.08% in 2024, then surged 1907.94% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $619042.0 in 2023, then plummeted by 90.69% to $57621.0 in 2024, then dropped by 25.45% to $42956.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $42956.0, $42956.0, and $773960.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.